H15.103
Unspecified episcleritis, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified bilateral episcleritis is a condition characterized by inflammation affecting the episclera, the thin layer of tissue covering the white part of the eye (sclera) in both eyes. This condition is part of a group of eye inflammations that can cause discomfort and redness but generally pose a low risk for vision loss. The term 'unspecified' indicates that the exact location or cause of the inflammation has not been determined, and 'bilateral' confirms that both eyes are affected.
Causes & Symptoms
Clinical Causes: Idiopathic origins, where the exact cause remains unknown Autoimmune diseases such as rheumatoid arthritis or lupus Viral infections like herpes simplex or varicella-zoster Bacterial infections, though less common Environmental triggers such as exposure to wind, dust, or sun Reaction to certain medications or topical agents Other systemic inflammatory conditions
Key Symptoms: Redness in both eyes, often prominent and diffuse Mild to moderate eye discomfort or irritation Sensation of grittiness or foreign body in the eyes Sensitivity to light (photophobia) Watery eyes or tearing Possible mild swelling of the episcleral tissue
Diagnostic & Treatment
Diagnosis Path: Diagnosis of bilateral episcleritis involves comprehensive eye examination and medical history review. An ophthalmologist may perform the following assessments:
Treatment Protocols: Management of unspecified bilateral episcleritis often involves symptomatic relief and addressing underlying causes when identified. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is H15.103 a billable ICD-10 code?
Yes, H15.103 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H15.103?
Clinical documentation must specify the nature of Unspecified episcleritis, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
